Regeneron Pharmaceuticals, Inc.Tarrytown, United States
Disclosure information not submitted.
Assessing treatment effectiveness when no appropriate comparator exists: low-density lipoprotein cholesterol lowering therapy (LLT) for the prevention of aortic stenosis (AS) as a case example
Monday, August 26, 20242:00 PM – 2:15 PM CEST
